Sanofi appoints Belén Garijo as new CEO after deciding not to renew current CEO Hudson's mandate

Group 1 - Sanofi has appointed Belén Garijo as the new CEO, replacing Paul Hudson, whose mandate will not be renewed [1][1][1] - Hudson will step down on February 17, while Garijo will officially take over after the shareholder meeting on April 29 [1][1][1] - Olivier Charmeil, a board member, will serve as interim CEO during the transition period [1][1][1] Group 2 - Belén Garijo has 15 years of experience at Sanofi and has held significant positions, including board member at L'Oreal and CEO of Merck KGaA [1][1][1] - The chairman of Sanofi, Frederic Oudea, expressed confidence in Garijo's ability to accelerate strategy execution and lead the company's next growth cycle [1][1][1]